StonvexLoading…
StonvexStonvexStonvexCore line items from MSGM's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $4.03M | $11.30M | $7.45M | $4.35M |
Operating Income | $1.06M | $3.25M | $2.67M | $1.87M |
Net Income | $315.83K | $6.93M | $6.09M | $5.30M |
EPS (Diluted) | $0.06 | $1.43 | $1.32 | $1.26 |
Total Assets | $13.88M | $11.97M | $10.10M | $8.15M |
Total Liabilities | $5.32M | $4.39M | $3.31M | $2.58M |
Cash & Equivalents | $5.86M | $4.99M | $4.13M | $2.37M |
Free Cash Flow OCF − CapEx | $1.63M | $4.06M | $2.33M | Not available |
Shares Outstanding | 5.48M | 4.84M | 4.62M | 4.20M |